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Abstract
Stem cells isolated from human exfoliated deciduous teeth (SHEDs) are a type of mes‐
enchymal stem cells (MSCs), widely investigated for regenerative treatment. They are 
isolated from dental pulp tissues remaining in physiologically shedding human decidu‐
ous teeth. Thus, SHEDs are easy to access and not required invasive procedure to obtain 
cells. SHEDs are multipotent mesenchymal stem cells; however, they possess distinct 
properties when compared to other MSCs. In this regard, SHEDs exhibit higher pro‐
liferative rate than bone marrow‐derived MSCs and greater osteogenic differentiation 
potency than human dental pulp stem cells. This chapter reviews the isolation technique 
and basic characteristics of SHEDs. Moreover, the intracellular signalling involved in the 
stemness regulation and differentiation ability of SHEDs is discussed, particularly on 
fibroblast growth factor, Notch, and Wnt signalling. Finally, the potential regenerative 
therapeutic application of SHEDs is also described.
Keywords: stem cells, deciduous teeth, basic fibroblast growth factor, Wnt signalling, 
Notch signalling, mechanical stress
1. Introduction
Dental pulp is a loose connective tissue residing in pulp chamber inside both deciduous and 
permanent teeth. It surrounds by hard tissues called dentin. Nutrients and oxygen supply 
are acquired from blood vessels passing through apical and accessory foramen of the teeth’s 
root. Dental pulp originates from cranial neural crest cells [1]. Dental pulp tissues are com‐
posed of extracellular matrix and various cell types, e.g. fibroblasts, odontoblasts, endothelial 
cells, pericytes, immune cells and stem cells. When injured, cells in dental pulp tissues are 
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capable of differentiating odontoblasts or odontoblast‐like cells, leading to the promotion of 
tertiary dentin formation. The formation of tertiary dentin is a mechanism which can protect 
the tooth vitality. Dental pulp tissues remaining in physiological shedding of deciduous teeth 
are the alternative source of mesenchymal stem cells, due to the ease of accessibility and mini‐
mally invasive technique to obtain tissues [2]. Stem cells from human exfoliated deciduous 
teeth (SHEDs) are firstly identified by Miura et al. in 2003 [2]. SHEDs have high proliferation 
potency and are multipotent mesenchymal stem cells. These cells are able to differentiate into, 
not only, dental pulp‐related cells, but also, other cell lineages, for example osteoblasts, adi‐
pocytes, neuronal‐like cells and endothelial cells [2–8]. Taking these advantageous properties 
together, SHEDs are one of the candidate cell types for tissue regeneration study.
2. SHEDs’ characteristics
SHEDs are heterogeneous population of cells isolated from dental pulp tissues remained in 
exfoliated deciduous teeth. Similar to those mesenchymal stem cells (MSCs), SHEDs exhibit 
fibroblast‐like morphology, adhere on plastic tissue culture surface, express mesenchymal 
stem cell surface marker and have multipotential differentiation ability (Figure 1). SHEDs 
have higher proliferation rate compared to dental pulp stem cells (DPSCs) and bone marrow‐
derived mesenchymal stem cells (BMMSCs) [2, 9]. This could be due to the high expression of 
genes related to cell proliferation and extracellular matrix in SHEDs comparing with DPSCs [9]. 
First, a study by Miura et al. demonstrated that SHEDs express mesenchymal surface markers, 
STRO‐1 and CD146 [2], though, the percentage of positive cells is low [2]. Later studies utilized 
various surface markers for SHEDs characterization protocol. SHEDs expressed CD44, CD73, 
CD90, CD105 and STRO‐1 [6]. In addition, these cells lack of CD45 expression [6]. Besides these 
markers described above, SHEDs also express other surface markers for example, CD166 and 
SSEA4. Lack of CD34 is also reported [10]. There is no specific surface marker to precisely iden‐
tify SHEDs population.
Up to date, MSCs can be isolated from many tissue types. Though, there is no specific marker 
to clearly identify these cells. According to the Mesenchymal and Tissue Stem Cell Committee 
of the International Society for Cellular Therapy, the minimum criteria to identify MSCs are as 
follow [11]. First, the isolated MSCs should adhere to plastic tissue culture plate [11]. Second, 
MSCs must express several specific surface markers, namely CD105, CD73 and CD90 [11]. 
They also should not express CD45, CD34, CD14 or CD11b, CD79α or CD19, and HLA‐DR 
[11]. Finally, MSCs have to be able to differentiate into osteoblasts, adipocytes and chon‐
droblasts in vitro [11]. The following section describes general SHEDs’ characteristics and 
addresses MSCs’ characteristics of SHEDs according to these criteria.
2.1. Isolation technique
Two methods have been utilized for SHEDs isolation, namely an enzymatic digestion and a tis‐
sue explant. The enzymatic digestion is performed by digesting minced remaining pulp tissues 
from deciduous teeth, normally with type I collagenase and dispase mixed enzyme  solution 
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[12–14]. For tissue explant, minced pulp tissues are placed on the tissue culture dishes, allowing 
the outgrowth of the cells from the tissues [12]. Enzymatic digestion technique leads to more 
heterogeneous population of isolated cells than those obtained from tissue outgrowth proto‐
col [14]. A study illustrated that there is no significant difference regarding cell morphology 
and proliferation between cells isolated using enzymatic digestion and tissue outgrowth [14]. 
Enzymatic digestion‐derived SHEDs had higher mineralization ability in vitro [14]. However, 
another study demonstrated that SHEDs isolated using enzymatic digestion exhibited higher 
cell proliferation and colony forming unit ability as well as adipogenic differentiation potency 
[13]. However, tissue explant‐derived SHEDs had higher osteogenic differentiation ability than 
enzymatic digestion‐derived SHEDs in vitro and in vivo [13]. The difference between these two 
studies, especially in osteogenic potential, may be due to the dissimilar osteogenic medium 
supplementation. The first study employed 0.01 μM dexamethasone disodium phosphate, 
1.8 mM monopotassium phosphate (KH
2
PO
4
) and 5 mM β‐glycerophosphate [14]. However, 
Figure 1. Characteristics of stem cells isolated from human exfoliated deciduous teeth. The expression of stem cells 
markers was evaluated using flow cytometry and conventional semi‐quantitative PCR (A and B). The osteogenic, 
adipogenic and neurogenic differentiation were evaluated at day 14, 16 and 7 after induction, respectively (C–E). The 
mineral deposition and intracellular lipid accumulation were determined using alizarin red and oil red O staining, 
respectively (C and D). The β3‐tubulin protein expression was evaluated by immunocytochemistry staining (E). The 
expression of differentiation marker was examined using conventional semi‐quantitative PCR. Reprinted from Archives 
of Oral Biology, 60(3), Nunthawan Nowwarote, Prasit Pavasant, Thanaphum Osathanon, Role of endogeneous basic 
fibroblast growth factor in stem cells isolated from human exfoliated deciduous teeth, 408–15, Copyright (2015), with 
permission from Elsevier [6].
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the osteogenic medium of later study was supplemented with 0.1 μM dexamethasone, 2 mM 
β‐glycerophosphate and 50 μM ascorbic acid‐2 phosphate [13]. Together, the different isola‐
tion technique resulted in the different population of SHEDs. Further comparison is needed to 
determine a suitable protocol for specific application of these cells.
2.2. Differentiation potential of SHEDs
Studies have shown that SHEDs possess multi‐differentiation potency similar to MSCs. Those 
lineages include odontogenic/osteoblastic, adipogenic, neurogenic and angiogenic differen‐
tiation [2].
2.2.1. Odontogenic/osteoblastic differentiation potential
The ability of SHEDs to differentiate into odontoblastic lineage is widely known [2, 15, 16]. 
Primitively, SHEDs were characterized by their in vivo osteoinductivity [2] and follow by several 
in vitro studies to confirm their odontogenic/osteoblastic differentiation potential [5, 10]. SHEDs 
showed similar osteogenic potency when comparing with BMMSCs, exhibiting significantly 
elevate levels of ALP activity after 1 week of induction. In addition, several osteogenic mark‐
ers such as RUNX2, DSP and OCN are also upregulated [10]. When cultured in an osteogenic 
medium, SHEDs formed mineralized nodules after 4 weeks of induction which indicate calcium 
deposition in vitro [2]. Transplantation of ex vivo expanded‐SHEDs with hydroxyapatite/trical‐
cium phosphate (HA/TCP) into immunocompromised mice also induced mineralized tissue 
formation [2]. Recently, osteoinductivity of SHEDs has been shown in mice. SHEDs formed an 
osteoinductive template in immunocompromised mice and induced the recruitment of native 
osteogenic cells to repair calvarial defects [16]. The osteogenic potential of SHEDs in regenerat‐
ing bone defects in maxillofacial region was also investigated by Zheng et al., the results found 
that autologous graft using stem cells from miniature pig primary teeth has the ability to regen‐
erate and repair mandibular defects [15]. SHEDs were able to regenerate bone tissues with blood 
vessels around dental implants in dog model when mixed with platelet‐rich plasma (PRP) [17].
Evidence suggested that SHEDs might have the preference towards the odontoblastic lineage 
due to its origin. SHEDs can be induced to become functional odontoblasts in vitro [2]. SHEDs 
can differentiate to become the odontoblast‐like cells and regenerate the tissue with archi‐
tecture and cellularity similar to the physiologic dental pulp when cultured in scaffolds pre‐
pared within human tooth slices and transplanted into immunodeficient mice [18]. It has been 
recently shown that SHEDs can generate functional dental pulp when injected with PuraMatrix 
or Collagen into root canals [19]. However, majority of the studies focusing on regenerating 
bone or dentin‐pulp complex in vivo were performed in ectopic implantation models, mostly 
in skin or renal capsule, in mice or rats [20–22] which might not close to real clinical situation. 
More studies in the clinical relevance area such as tooth socket or jaw bone in larger animals 
such as pig or dog should be considered to make the results more valuable for application.
2.2.2. Neurogenic differentiation potential
Neurogenic potential of SHEDs is expecting due to their neural crest embryonic origin. Several 
research studies focusing on differentiating dental stem cells to be used for  neurodegenerative 
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disease therapy. These cells are prone to undergo neurogenic differentiation both in vitro and 
in vivo. Under the undifferentiating condition, SHEDs and other dental stem cells expressed 
the neural progenitor markers, nestin and the glial marker, glial fibrillary acidic protein 
(GFAP), at both the mRNA and protein levels [2, 23]. SHEDs can be induced to become a 
variety of specialized cells in neural lineage including dopaminergic neuron like cells and 
glial cells [24, 25]. When induced, SHEDs could form neural‐like spheres in vitro. Further 
incubation with a combination of cytokines including sonic hedgehog, fibroblast growth fac‐
tor 8, glial cell line‐derived neurotrophic factor and forskolin can drive these neural spheres 
into the dopaminergic like neurons [25]. A similar trend was observed where SHEDs showed 
positive expression of both glial and neuronal markers after 21 days of neurogenic induction. 
Deposition of antimyelin basic protein was seen and the differentiated cells showed positive 
expression for neuronal markers such as βIII‐tubulin, apolipoprotein E (ApoE), intermediate 
filament peripherin and Brn3a [26]. SHEDs are able to differentiate into dopaminergic neuro‐
nal like cells in vitro [27]. However, SHEDs exhibited inferior differentiation ability towards 
dopaminergic neurons as compared with DPSCs [28]. In this regard, DPSCs upregulated 
dopaminergic neuron markers (Nurr1, Engrailed1 and Pitx3) higher than SHEDs after treated 
with sonic hedgehog, fibroblast growth factor 8 and basic fibroblast growth factor [28].
In vivo studies also show the promising results for generating the specialized cells in the neu‐
ral system. Transplantation of neural‐like spheres derived from SHEDs into the striatum of 
parkinsonian rats significantly improved the apomorphine‐evoked rotation of behavioural 
impairment compared to transplantation of control SHEDs [25]. The results were in line with 
another study showing the partially recovery after inducing neural maturation of SHEDs 
into dopaminergic neuron‐like cells and transplantation in parkinsonian rats [27]. Moreover, 
a complete recovery of hindlimb motor function was observed after implantation of neural‐
induced SHEDs in a rat spinal cord injury [29]. These results suggested that pre‐induction 
of the undifferentiated SHEDs into the neural‐like cells before implantation might improve 
the efficiency of SHEDs in regenerating specialized neural cells and potentially improve the 
treatment outcome.
2.2.3. Angiogenic differentiation potential
Angiogenic potential of SHEDs is another aspect of interest for the benefit of connective tissue 
regeneration. The rapid and effective induction of vasculation is required for sufficiently sup‐
ply of oxygen and nutrients as well as removing the toxic waste from the newly synthesized 
tissues. Unstimulated SHEDs expressed VEGFR1 and NP‐1, the known important receptors 
in angiogenesis and VEGFR1 signalling play an important role in VEGF‐induced capillary 
tube formation by SHEDs as shown by VEGFR1 gene silencing [30]. SHEDs cultured in the 
tooth slice/scaffolds in combine with VEGF expressed several endothelial differentiation 
markers such as VEGFR1, VEGFR2, platelet endothelial cell adhesion molecule‐1 (PECAM‐1) 
and vascular endothelial cadherin (VE‐Cadherin). When transplanted in immunodeficient 
mice, SHEDs actually lined the new blood vessels within the tooth slice/scaffolds close to the 
blood vessels of host [3]. Similar results were observed when SHEDs seeded in human tooth 
slice/scaffolds and transplanted into immunodeficient mice differentiate into human blood 
vessels that anastomosed with the mouse vasculature and VEGF induced the angiogenic 
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 differentiation of SHEDs through Wnt/β‐catenin signalling [31]. Another study also showed 
that SHEDs can differentiate into VEGFR2‐positive and CD31‐positive endothelial cells in 
vitro. This phenomenon occurred via VEGF/MEK‐1/ERK signalling pathway [30]. In addition 
to in vitro data, an in vivo study also showed that SHEDs differentiate into endothelial cells 
when seeded in biodegradable scaffolds and transplanted into immunodeficient mice [18], 
confirming the plasticity of SHEDs.
2.2.4. Adipogenic differentiation potential
Several studies have reported that SHEDs can be induced into adipogenic lineage [6, 32–34]. 
After cultured in an adipogenic medium, SHEDs’ morphology changed from spindle‐like to 
polygonal shapes and lipid vacuoles were observed, along with the increased in PPARγ2 and 
LPL mRNA [32]. However, the studies evaluated the adipogenic potential of SHEDs in vivo 
are sparse and the clinical application may not come in the near future.
2.3. Immunomodulatory property
Like other MSCs, SHEDs exhibit immunomodulatory properties. Though, the potency and 
mechanism are not exact the same to those of BMMSCs [10, 35]. SHEDs significantly reduced 
the percentage of IL17+IFNγ cells population in CD4+ T cells in vitro [10]. In addition, IL17 
expression was decreased compared with the naïve T cell culture alone [10]. SHEDs were also 
able to rescue the systemic lupus erythematosus‐associated symptoms in mice by increas‐
ing the ratio of regulatory T cells [10]. It has also been shown that acetylsalicylic acid treat‐
ment could improve the immunomodulation of SHEDs [36]. In this regard, acetylsalicylic 
acid‐treated SHEDs enhanced apoptosis of T cells and reduction of IL17+IFNγ cells via TERT/
FASL pathway [36]. SHEDs also modulate dendritic cell maturation. When co‐culture with 
SHEDs, mature dendritic cells decreased CD40, CD80, CD83 and CD86 expression [37]. 
SHEDs treating monocyte‐derived dendritic cells reduced CD4+ and CD8+ cell proliferation 
when co‐culture with peripheral blood lymphocyte as compared to the control [37]. These 
immunomodulatory functions of SHEDs encourage them as an interesting MSCs source for 
regenerative therapy.
3. Basic fibroblast growth factor signalling in SHEDs
Basic fibroblast growth factor (bFGF) is a member in fibroblast growth factor family [38]. 
It binds to fibroblast growth factor receptors (FGFR) and further initiates intracellular sig‐
nalling [39]. bFGF has been shown to participate in the regulation of stemness maintenance 
and cellular differentiation. In human DPSCs, bFGF promotes pluripotent stem cell marker 
expression, corresponding with the increase of colony‐forming unit [40]. Furthermore, bFGF 
inhibits osteogenic differentiation by SHEDs, human DPSCs and human periodontal ligament 
stem cells (PDLSCs) when supplemented in osteogenic induction medium (Figure 2) [5, 40]. 
In this regard, alkaline phosphatase enzymatic activity and mineralization are markedly 
decreased under bFGF‐treated condition compared with the control [5, 40]. On the contrary, 
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bFGF enhances the expression of neurogenic marker, βIII‐tubulin, via FGFR and PLCγ when 
human DPSCs are cultured in a neurogenic induction medium supplemented with bFGF [40].
In SHEDs, long‐term culture in vitro leads to the decrease of stemness as determined by the 
reduction of pluripotent stem cell markers, i.e. OCT4, NANOG and REX1 [41]. In addition, the 
reduction of colony‐forming unit ability is observed in high passage (passage 10) of cells [41]. 
Interestingly, bFGF enhanced OCT4, NANOG and REX‐1 mRNA levels in both short‐ and 
long‐term maintaining in vitro [41]. bFGF also increased colony‐forming unit in passage 10 
[41]. Similarly, an attenuation of endogenous bFGF expression or blocking FGFR results in 
Figure 2. bFGF inhibited ALP expression and mineral deposition. The attenuation of ALP mRNA expression by bFGF at 
7 days in normal and osteogenic medium was illustrated (A and B). The ALP enzymatic activity in osteogenic medium 
was shown at 7 and 14 days (C and D). Mineral deposition was determined at 14 days after maintaining in osteogenic 
medium (E and F). The time course experiments illustrated that bFGF attenuated ALP mRNA expression at 1, 3 and 
5 days after cultured under osteogenic induction condition (G and H). The influence of bFGF was confirmed using 
FGFR inhibitor (SU5402). The ALP mRNA expression at 3 days was evaluated in osteogenic condition (OM), osteogenic 
condition supplemented with bFGF (bFGF) and osteogenic condition supplemented with bFGF and SU5402 (bFGF + 
SU5402) (I and J). The asterisk indicated the statistical significance compared to the control. Reprinted from Journal 
of Cellular Biochemistry, 114(11), Thanaphum Osathanon, Nunthawan Nowwarote, Jeeranan Manokawinchoke, Prasit 
Pavasant, bFGF and JAGGED1 regulated alkaline phosphatase expression and mineralization in dental tissue‐derived 
mesenchymal stem cells, 2551–61, Copyright (2013), with permission from John Wiley & Sons Inc. [5].
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the reduction of colony‐forming number by SHEDs [6]. Further, bFGF promotes colony‐form‐
ing unit ability in SHEDs isolated from inflamed dental pulp tissues [42]. For the regulatory 
mechanism, it has been demonstrated that bFGF regulated REX‐1 expression in SHEDs via 
FGFR and Akt pathway [34]. IL‐6 is also shown to involve in bFGF induced REX‐1 expression 
as pre‐treatment with antibody against IL‐6 attenuates REX‐1 expression [34].
Regarding osteogenic differentiation, bFGF attenuated osteogenic differentiation. In this 
regard, bFGF attenuated alkaline phosphatase enzymatic activity and mineralization in SHEDs 
after osteogenic induction [5, 43]. The inhibition of endogenous bFGF in SHEDs either by a 
chemical inhibitor for FGFR or lentiviral shRNA against bFGF resulted in the enhancement of 
osteogenic differentiation [6]. It was also demonstrated that bFGF attenuated alkaline phos‐
phatase mRNA expression and mineral deposition via FGFR and MEK signalling pathway [5].
Several possible mechanisms were reported. Firstly, bFGF might attenuate osteogenic dif‐
ferentiation in SHEDs via decreasing Notch signalling [5]. Notch signalling activation led 
to the enhancement of mineralization in SHEDs [7]. Treatment with bFGF attenuated Notch 
receptor, ligand and target gene expression which may participate in bFGF attenuated osteo‐
genic differentiation in SHEDs [5]. Secondly, bFGF inhibited matrix metalloproteinase (MMP) 
expression, for example MMP‐2, MMP‐13 and MT1‐MMP [5]. It has been demonstrated that 
MMP2 influenced odontogenic differentiation by DPSCs [44]. In this regard, MMP2 cleaved 
dentin matrix protein 1 (DMP1), resulting in the release of bioactive peptide that could pro‐
mote odontogenic differentiation of DPSCs [44]. Finally, it has been shown that bFGF might 
inhibit canonical Wnt signalling pathway via the activation of ERK1/2 signalling [43]. ERK 
attenuation rescued bFGF inhibiting osteogenic differentiation by SHEDs both in vitro and 
in vivo [43]. In addition, ERK inhibitor increase β‐catenin levels in bFGF‐treated SHEDs 
[43]. Besides odonto/osteogenic differentiation, it has been shown that bFGF participated in 
angiogenesis induction properties of SHEDs. Priming with bFGF promoted SHEDs‐induced 
angiogenesis in vivo [45]. This could be due to the increase production of VEGF and HGF by 
bFGF‐treated SHEDs [45]. Together, these data denote the crucial influence of bFGF in the 
regulation of SHEDs stemness and differentiation mechanisms.
4. Wnt signalling in SHEDs
Canonical Wnt signalling also has a significant role in tooth development and stem cells self‐
renewal through β‐catenin [46, 47]. Inactivation of β‐catenin in the mesenchyme of devel‐
oping tooth results in arrested tooth developmental at the bud stage [48]. Various studies 
established the influence of canonical Wnt signalling pathway to promote the osteogenic dif‐
ferentiation of dental stem cells, i.e. DPSCs, PDLSCs, stem cells from apical papilla (SCAPs) 
and dental follicle stem cells (DFSCs) [49–52]. However, the effect of the canonical Wnt/ β‐
catenin on SHEDs is very limited. The involvement of Wnt/β‐catenin on SHEDs‐mediated 
mineralized tissue regeneration was investigated with the addition of basic fibroblast growth 
factor (bFGF) [43]. Treatment with bFGF attenuated SHEDs‐mediated mineralized tissue 
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regeneration via activation of ERK 1/2 pathway and consequently inhibited Wnt/β‐catenin 
pathway, leading to osteogenic deficiency of SHEDs [43].
A recent in vitro and in vivo study reported that an activation of the canonical Wnt signal‐
ling pathway induced by Wnt3A can promote osteogenic differentiation of DPSCs [52]. 
Similar to previous study that activated Wnt signalling by using various concentrations of 
lithium chloride (LiCl), the result showed that Wnt/β‐catenin strongly upregulated expres‐
sion of dentin sialophosphoprotein (DSPP), OCN and ALP in time‐ and dose‐dependent 
manner [50, 51]. LiCl also upregulated protein expression of osteogenic transcription fac‐
tors, including RUNX2, MSX2 and OSX. Whereas cells treated with Dickkopf‐1 (DDK1), 
an inhibitor for canonical Wnt signalling, resulted in the inhibition of osteogenic mRNA 
expression and reduction the alkaline phosphatase enzymatic activity and matrix mineral‐
ization [50]. On the other hand, the contradictory evidence demonstrates that the canoni‐
cal Wnt signalling can inhibit osteogenic differentiation, alkaline phosphatase enzymatic 
activity and formation of mineralized nodules in DPSCs [53]. Canonical Wnt signalling 
inhibited the odontoblast‐like differentiation of DPSCs was first reported by Scheller et al. 
in 2008 [53]. This study showed that Wnt‐1 inhibited alkaline phosphatase enzymatic activ‐
ity and the formation of mineralized nodules in DPSCs when transduced with canonical 
Wnt‐1 or the active form of β‐catenin, with retrovirus‐mediated infection. Moreover, over‐
expression of β‐catenin was also sufficient to suppress the differentiation and mineraliza‐
tion of DPSCs [53]. Another study was established using Wnt3A and LiCl to examine the 
possible involvement of canonical Wnt signalling in regulating cementoblast behaviours. 
Activation of endogenous canonical Wnt signalling with both Wnt3A and LiCl suppressed 
alkaline phosphatase enzymatic activity and expression of genes associated with cemen‐
tum function: Alp, Bsp and Ocn. This effect was accompanied by decreased gene expression 
of Runx2 and Osx and by increased gene expression of Lef‐1. In conclusion, these observa‐
tions suggest that Wnt signalling inhibits cementoblast differentiation and promotes cell 
proliferation [54].
Activation of β‐catenin by LiCl in SHEDs led to the significant decrease of colony formation 
by SHEDs [55]. In addition, LiCl enhanced subG0 population in SHEDs [55]. OSX and DMP1 
mRNA expression was markedly decreased in LiCl‐treated SHEDs. These results imply the 
influence of Wnt signalling in SHED behaviours [55]. The canonical Wnt/β‐catenin pathway 
also implicates in angiogenic differentiation of SHEDs. Transplantation of SHEDs in human 
tooth slice/scaffolds into immunodeficient mice differentiates into new blood vessels that anas‐
tomose with the host vasculature. In vitro data showed that VEGF induced the vasculogenic 
differentiation of SHEDs via potent activation of Wnt/β‐catenin signalling while Wnt inhibi‐
tion blocked this process [31]. Moreover, the study has been shown that the Wnt/β‐catenin 
pathway also participates in immunomodulatory properties of SHEDs [36]. Acetylsalicylic 
acid treatment enhances immunomodulatory properties of SHEDs as indicated by increased 
in SHED‐mediated T‐cell apoptosis and the decreased levels of T helper 17. Moreover, ace‐
tylsalicylic acid significantly improves SHED‐based bone formation and these effects of ace‐
tylsalicylic acid treatment on SHEDs occurred via the regulation of the telomerase reverse 
transcriptase/Wnt and TERT/FASL pathways [36].
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5. Notch signalling in SHEDs
Notch signalling controls various function of stem cells, ranging from stemness mainte‐
nance to cell‐specific differentiation [56]. It is a highly conserved pathway, firstly identified 
in Drosophila. Notch signalling is initiated by the binding between membrane‐bound Notch 
receptors and ligands of neighbouring cells [56–58]. Further, Notch receptors are cleaved by 
a γ‐secretase enzyme, leading to the release of Notch intracellular domain (NICD) [56–58]. 
Subsequently, NICD translocates into nucleus and forms complex with other transcriptional 
molecules, resulting in the activation of Notch target genes [56–58]. Common Notch signal‐
ling target genes are Hes and Hey families [56–58]. In the canonical Notch signalling pathway, 
four receptors and five ligands are identified [56–58]. The four types of Notch receptors are 
Notch1, Notch2, Notch3 and Notch4. Five ligands are Delta‐like‐1 (Dll‐1), Delta‐like‐3 (Dll‐3), 
Delta‐like‐4 (Dll‐4), Jagged1 and Jagged2 [56–58].
Notch signalling participates in odontogenesis, dental pulp repair and regeneration. Mice lack‐
ing of Jagged2 expression exhibited defective enamel formation of incisors and malformation 
of molars [59]. The expression of Notch receptors and ligands was upregulated in response 
to calcium hydroxide, a material for direct pulp capping treatment [60]. Human DPSCs over‐
expressing Jagged1 exhibited the reduction of osteogenic differentiation ability and mineral‐
ization in vitro and in vivo [61]. Dll‐1 over‐expressing human DPSCs had higher proliferative 
rate than the control and knock down Dll‐1 expression in human DPSCs led to significantly 
enhancement of osteo/odontogenic differentiation [62, 63]. These evidence support the role of 
Notch signalling in the regulation of human DPSCs’ behaviours and dental pulp tissue homeo‐
stasis of permanent teeth. Though, knowledge of Notch signalling in SHEDs is yet limited.
Studies illustrated that indirectly immobilized Notch ligands, Jagged1 or Dll‐1, on tissue 
culture surface increased HES1 and HEY1 mRNA levels in SHEDs, implying the successful 
activation of intracellular Notch signalling [7]. The activation of Notch signalling in SHEDs 
led to the enhancement of osteogenic differentiation [5, 7]. However, Jagged1 exhibited 
higher potency to promote alkaline phosphatase enzymatic activity and mineralization than 
Dll‐1 (Figure 3) [7]. Corresponding to study in primary human dental pulp cells isolated 
from deciduous teeth, Jagged1, but not Dll‐1, attenuated cell proliferation [64]. The influence 
of Jagged1 on alkaline phosphatase enzymatic activity and mineralization in vitro could be 
attenuated by pretreatment with a γ‐secretase inhibitor, DAPT, confirming the involvement 
of Notch signalling pathway [7]. Jagged1 significantly enhanced osteogenic marker gene 
expression, namely ALP and COL1 [7]. In addition, Jagged1 downregulated a negative regu‐
lator of osteogenic differentiation, TWIST2, in SHEDs [7].
It has been shown that bFGF inhibited the mRNA expression of Notch signalling components. 
In this regard, bFGF significantly reduced the mRNA levels of NOTCH1, NOTCH2, JAGGED1, 
DLL1 and HES1 in SHEDs cultured in osteogenic induction medium [5]. In addition, bFGF 
was able to attenuate Jagged1‐induced alkaline phosphatase mRNA expression and mineral‐
ization when SHEDs were maintained in osteogenic medium for 7 and 14 days, respectively 
[5]. bFGF significantly reduced alkaline phosphatase mRNA expression as early as 1 day in 
culture, corresponding to the significant reduction of HES1 [5]. Taken all evidence together, 
bFGF and Notch signalling possibly interact and regulate mineralization process in SHEDs.
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6. Mechanical stress influences SHEDs’ behaviours
Dental pulp tissues are surrounded by hard tissues, namely dentin. During inflammation, an 
interstitial fluid pressure increases [65, 66], causing biological changes in local cells and tis‐
sues. In addition, fluid movement in dentin‐pulp complex during normal occlusal force may 
expose cells to mechanical stimuli [67]. Mechanical forces are shown to regulate biological 
functions in many cell types, for example osteoblasts, osteocytes, periodontal ligament cells 
and dental pulp cells. Different types and magnitude of force lead to different cell responses. 
Figure 3. Effects of Dll‐1 and Jagged1 on osteogenic differentiation. The alkaline phosphatase enzymatic activity (A) and 
mineralization (B) were evaluated at day 7 and 14 after osteogenic induction, respectively. For osteoblast marker gene 
expression, cells were cultured on Dll‐1, Jagged1 or hFc treated surface for 7 days after osteogenic differentiation. The 
graphs demonstrated the relative mRNA expression of ALP, COL1, OPN and OCN upon seeding cells on Dll‐1 or Jagged1 
immobilized surface and normalized to the hFc control (D–F). Asterisks indicated statistical significance compared to 
the hFc control. Reprinted from Archives of Oral Biology, 65, Waleerat Sukarawan, Kannapas Peetiakarawach, Prasit 
Pavasant, Thanaphum Osathanon, Effect of Jagged1 and Dll‐1 on osteogenic differentiation by stem cells from human 
exfoliated deciduous teeth, 1–8, Copyright (2016), with permission from Elsevier [7].
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In human DPSCs, uniaxial cycle stretching inhibited odonto/osteogenic differentiation but 
increased cell proliferation [68, 69], while cyclic hydrostatic pressure synergistically enhanced 
BMP‐2‐induced DSPP expression by human DPSCs in vitro and increased hard tissue forma‐
tion in vivo [70]. Studies in SHEDs demonstrate that mechanical force may regulate stem‐
ness maintenance. In this respect, static compressive force upregulated pluripotent marker 
mRNA expression in SHEDs [8]. REX‐1, SOX2, OCT4 and NANOG mRNA levels increased 
in a magnitude‐dependent manner [8]. Mechanical stress‐induced REX‐1 expression is partly 
controlled via IL‐6/JAK and ATP‐P2Y1 signalling pathways [8, 71]. Though, the clinical sig‐
nificance of these phenomena requires further investigation.
7. Potential application of SHEDs in regenerative therapy
SHEDs are the good candidate for the stem cells used in regenerative therapy due to their 
high plasticity as well as ability to cross lineage boundaries and differentiate into several 
specialized cells. Current progresses have been made for tissue engineering‐based therapies 
involving a large number of tissues. However, dentin‐pulp complex and neuronal tissue seem 
to be the most promising aspects for the application of SHEDs in regenerative therapy.
The first evidence to show that SHEDs can differentiate to become the functional odontoblasts 
with the ability to generate the mineralized tissue resemble to dentin was shown in mice [3]. 
SHEDs were seeded within a scaffold in a tooth slice and implanted into the dorsum of mice. 
Dental pulp‐like tissue was observed in the central area of the pulp chamber of the tooth 
slice [3]. The expression of odontoblastic differentiation markers such as DSPP and DMP‐1 
was detected [3]. Remarkably, the newly deposited dentin was observed and suggested that 
SHEDs can differentiate into fully functional odontoblasts in vivo [3]. Later in 2013, the regen‐
eration of the dental pulp within the full length of the root canal was reported [19]. SHEDs 
were transplanted into the root canals with the scaffold and were observed for 28 days in vitro. 
The transplanted SHEDs were able to proliferate and inside the root canal [19]. The expression 
of odontoblastic differentiation marker such as DSPP, DMP‐1 and MEPE was observed [19]. 
Interestingly, when the roots with SHEDs were implanted in the subcutaneous space of mice, 
a dental pulp‐like tissue was formed in the majority of space in the root canal [19]. This de novo 
dental pulp‐like tissue was capable of depositing new dentin [19]. However, this model is still 
considered as the ectopic transplantation model. Another concern for clinical translation is that 
most of the results interpretation was made from histological evaluation with the lack of func‐
tional testing. Therefore, the regeneration of dentin‐pulp complex by SHEDs still needs further 
study in the more related oral environment and the additional functional of nerve innervation 
or vascularization should be performed before clinical application. Current possible experi‐
mental approaches for dentin pulp complex regeneration are summarized in Figure 4.
In addition to dentin‐pulp complex regeneration, SHEDs also show the potential to be used 
in neuroregeneration. Stem cell therapy is the promising therapeutic options for treating the 
neurodegenerative diseases due to the limited regenerative capacity of the specialized cells 
in the nervous system. The neural crest cell in origin makes SHEDs the candidate cell model 
for neuron tissue regeneration. These cells are prone to undergo neurogenic differentiation 
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both in vitro [2, 24–26] and in vivo [25, 27, 72]. Promising results from several in vivo studies 
lay the spotlight on SHEDs for their use as a stem cell source for treating neurodegenerative 
disease and other neuron‐related conditions such as Parkinson disease, Alzheimer’s disease, 
focal cerebral ischemia and spinal cord injuries [27, 29, 72–74]. Transplantation of neurogenic 
induced SHEDs into the parkinsonian rat model significantly improved the recovery behav‐
ioural impairment compared to transplantation of control SHEDs [25, 27].
In a focal cerebral ischemia rat model induced by permanent middle cerebral artery occlusion, 
intranasal administration of supernatants from the medium used to culture SHEDs signifi‐
cant decreased in the motor disability score and significantly reduced in the infarct volume 
[72]. Moreover, positive signals for neuronal nucleus, neurofilament H, doublecortin and rat 
endothelial cell antigen in the peri‐infarct area were observed in the rats treated with SHEDs 
conditioned media compared to the DMEM control from approximately 140 mm3 in DMEM 
control to 50 mm3 in SHEDs conditioned medium [72]. These results suggest that SHEDs 
might secrete some compounds that positively influence the recovery of the brain lesion in 
focal cerebral ischemia [72].
Studies have shown that SHEDs have remarkable neuroregenerative activity and promote func‐
tional recovery in a spinal cord injury animal model [29, 75]. Rats that received SHEDs trans‐
plantation within the lesion created at the 9th–11th thoracic vertebral levels exhibited higher 
scores in the locomotor rating scale compared to the bone marrow stromal cells or fibroblasts 
transplantation control [75]. In addition, the rescue of hindlimb locomotor function was promi‐
nent in the rats that received SHEDs. These animals were able to move hindlimb coordinately 
and walk, while the bone marrow stromal cells transplantation exhibited only subtle movements 
Figure 4. Current possible experimental approaches for dentin pulp complex regeneration using SHEDs.
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[75]. A similar trend was observed in another study, a complete recovery of hindlimb motor 
function was observed after implantation of neural‐induced SHEDs in a rat spinal cord injury 
[29] which suggested that preinduction of the undifferentiated SHEDs into the neural‐like cells 
before implantation might improve the efficiency of SHEDs in regenerating specialized neural 
cells. Taken together, these high neurogenic potential of SHEDs especially in animal models 
makes them the favourable source for stem cell regeneration treatment for neural diseases.
8. Conclusion
Dental stem cells, including SHEDs, have been extensively studied in the past decades lead‐
ing to the better understanding in their unique biological properties and therapeutic poten‐
tial. As SHEDs can be easily obtained with limited ethical concern, their multi‐differentiation 
potentials have been demonstrated, which creates great opportunities for the application in 
the regenerative therapy. However, despite the intriguing results, we still need further study 
to deepen the understanding of the mechanisms underlying the differentiation processes to 
attain clinical reality. Also, the potential risks for the clinically use of SHEDs or other dental 
stem cells should be thoroughly studied for the safety of the patients who will greatly benefit 
from their regenerative ability.
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